SIK2 and breast cancer: Zong et al. [55] reported that salt-inducible kinase (SIK2), a member of adenosine monophosphate- (AMP-) activated protein kinase family, was beneficial for cisplatin resistance caused by aerobic glycolysis in BC cells via modulating the AKT/mTOR pathway.